PDLIM5 and cardiovascular disorder: The miR-17-92 cluster participates in normal development, skeletal myogenesis, immune disease, cardiovascular disease, and tumorigenesis (26, 27), of which miR-20a, miR-92, and miR-17 regulate the proliferation of myoblasts but inhibit their differentiation by targeting ENH1.